Journal article
Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
DJ Jonker, CS Karapetis, C Harbison, CJ O'Callaghan, D Tu, RJ Simes, DP Malone, C Langer, N Tebbutt, TJ Price, J Shapiro, LL Siu, RPW Wong, G Bjarnason, MJ Moore, JR Zalcberg, S Khambata-Ford
British Journal of Cancer | NATURE PUBLISHING GROUP | Published : 2014
DOI: 10.1038/bjc.2013.753
Grants
Funding Acknowledgements
This work was supported by the Canadian Cancer Society through the NCIC Clinical Trials Group, ImClone Systems and Bristol-Myers Squibb.